Treatment Average LDL-C Reduction
Moderate intensity statin (other than rosuvastatin 20-40 mg or atorvastatin 40-80 mg) ≈ 30%
High intensity statin (rosuvastatin 20-40 mg or atorvastatin 40-80 mg) ≈ 50%
High intensity statin + ezetimibe ≈ 65%
PCSK9i as monotherapy ≈ 60%
PCSK9i + high intensity statin ≈ 75%
PCSK9i + high intensity statin + ezetimibe ≈ 85%